MEDIATION OF DOPAMINE-D(1) AND DOPAMINE-D(2) RECEPTORS IN THE EFFECTS OF GBR-12909 ON LATENT LEARNING AND LOCOMOTOR-ACTIVITY IN MICE

被引:14
作者
ICHIHARA, K
NABESHIMA, T
KAMEYAMA, T
机构
[1] NAGOYA UNIV,SCH MED,DEPT NEUROPSYCHOPHARMACOL & HOSP PHARM,SHOWA KU,NAGOYA,AICHI 466,JAPAN
[2] MEIJO UNIV,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,NAGOYA,AICHI 468,JAPAN
关键词
DOPAMINE-D(1) RECEPTORS; DOPAMINE-D(2) RECEPTORS; GBR-12909; LEARNING (LATENT); LOCOMOTOR ACTIVITY;
D O I
10.1016/0014-2999(93)90949-I
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the involvement of dopamine D1 and D2 receptor subtypes in the effects of GBR 12909, a selective dopamine uptake inhibitor, on latent learning in the performance of a water-finding task and on locomotor activity in mice. GBR 12909 (10 and 20 mg/kg) impaired latent learning, and this effect was counteracted by the dopamine D2 receptor antagonist, (-)-sulpiride (20 and 40 mg/kg), but not by the dopamine D1 receptor antagonist, SCH 23390 (0.025 and 0.05 mg/kg). The dopamine D2 receptor agonist, quinpirole (0.5 and 1 mg/kg) and the dopamine D1 receptor agonist, SKF 38393 (20 mg/kg) impaired latent learning, but both effects were less than that of GBR-12909. The effect of quinpirole, but not of GBR 12909, on latent learning was potentiated by combination with SKF 38393. In contrast to its effect on learning, SCH 23390 (0.025 and 0.05 mg/kg) was more effective to suppress the stimulant effect of GBR 12909 on locomotor activity than was (-)-sulpiride (40 and 80 mg/kg). These findings suggest that both dopamine D1 and D2 receptors play an important role in the action of endogenously released dopamine in latent learning and locomotor activity, and that while the dopamine D2 receptor is involved predominantly in latent learning, both dopamine D1 and D2 receptors play a critical role in locomotor activity.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 34 条
[1]   EFFECTS OF APOMORPHINE AND HALOPERIDOL ON EXPLORATORY-BEHAVIOR AND LATENT LEARNING IN MICE [J].
AHLENIUS, S ;
ENGEL, J ;
ZOLLER, M .
PHYSIOLOGICAL PSYCHOLOGY, 1977, 5 (03) :290-294
[3]   DOPAMINE RECEPTOR AGONISTS - SELECTIVITY AND DOPAMINE-D1 RECEPTOR EFFICACY [J].
ANDERSEN, PH ;
JANSEN, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :335-347
[4]   DOPAMINE D-1 RECEPTOR AGONISTS COMBINED WITH THE SELECTIVE D-2 AGONIST QUINPIROLE FACILITATE THE EXPRESSION OF ORAL STEREOTYPED BEHAVIOR IN RATS [J].
ARNT, J ;
HYTTEL, J ;
PERREGAARD, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (02) :137-145
[5]   THE D-1 DOPAMINE RECEPTOR ANTAGONIST SCH 23390 ALSO INTERACTS POTENTLY WITH BRAIN-SEROTONIN (5-HT2) RECEPTORS [J].
BISCHOFF, S ;
HEINRICH, M ;
SONNTAG, JM ;
KRAUSS, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 129 (03) :367-370
[6]   OBLIGATORY D-1 D-2 RECEPTOR INTERACTION IN THE GENERATION OF DOPAMINE AGONIST RELATED BEHAVIORS [J].
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) :301-306
[7]   VASOPRESSIN POTENTIATION IN THE PERFORMANCE OF A LEARNED APPETITIVE TASK - REVERSAL BY A PRESSOR ANTAGONIST ANALOG OF VASOPRESSIN [J].
ETTENBERG, A ;
LEMOAL, M ;
KOOB, GF ;
BLOOM, FE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 18 (04) :645-647
[8]   BEHAVIORAL PROPERTIES OF GBR-12909, GBR-13069 AND GBR-13098 - SPECIFIC INHIBITORS OF DOPAMINE UPTAKE [J].
HEIKKILA, RE ;
MANZINO, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 103 (3-4) :241-248
[9]   5HT-RECEPTOR ANTAGONIST PROPERTIES OF SCH 23390 IN VASCULAR SMOOTH-MUSCLE AND BRAIN [J].
HICKS, PE ;
SCHOEMAKER, H ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (3-4) :339-342
[10]   CHARACTERISTICS OF THE AMBULATION-INCREASING EFFECT OF GBR-12909, A SELECTIVE DOPAMINE UPTAKE INHIBITOR, IN MICE [J].
HIRATE, K ;
KURIBARA, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1991, 55 (04) :501-511